Effects of the angiotensin receptor blocker, telmisartan, on cardiovascular events in high-risk patients intolerant to ACE-inhibitors. Erratum of Vol 372(9644):1174-83
Authors
Dyal L.
Schumacher H.
Pogue J.
Sleight P
TRANSCEND Investigators Writing Committee
Koon K.
Copland I.
Yusuf S.
Anderson Craig
Chalmers J.
Type of Publication
Journal Article
